FDA Grants AP Status for Piroxicam ANDA206152 by Micro Labs
The FDA has granted an Abbreviated New Drug Application (ANDA) approval status of 'AP' for Piroxicam submitted by Micro Labs.
Therapeutic Area
Therapeutic area intelligence for NSAID with 9 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.